Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal cerebral morphology (HP:0002060)help
Grandparent Node:
expand
Ectopic calcification (HP:0010766)help
Parent Node:
expand
Abnormal basal ganglia morphology (HP:0002134)help
Parent Node:
expand
Cerebral calcification (HP:0002514)help
..Starting node
..expand
Basal ganglia calcification (HP:0002135)help
Term ID: 2135
Name: Basal ganglia calcification
Synonym: Basal ganglia calcifications; Basal ganglion calcification; Calcification of the basal ganglia
Definition: The presence of calcium deposition affecting one or more structures of the basal ganglia.
Comments:
Reference: HP:0002135
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandBilateral intracerebral calcifications (HP:0005671) help
..expandCalcification of falx cerebri (HP:0005462) help
..expandChoroid plexus calcification (HP:0006960) help
..expandCongenital intracerebral calcification (HP:0006906) help
..expandDiffuse cerebral calcification (HP:0005849) help
..expandIntracerebral periventricular calcifications (HP:0007229) help
..expandMeningeal calcification (HP:0100250) help
..expandMidline brain calcifications (HP:0007045) help
..expandNonarteriosclerotic cerebral calcification (HP:0007238) help
..expandPituitary calcification (HP:0010513) help
..expandSubcortical white matter calcifications (HP:0007346) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002135HP:0002135Basal ganglia calcification0ACVR1 CL E G H90171OMIM:135100Fibrodysplasia ossificans progressivaHP:0040284 - Very rare49
HP:0002135HP:0002135Basal ganglia calcification0CA2 CL E G H7601373ORPHA:2785Osteopetrosis with renal tubular acidosis29
HP:0002135HP:0002135Basal ganglia calcification0CA2 CL E G H7601373OMIM:259730Osteopetrosis, autosomal recessive 3.29
HP:0002135HP:0002135Basal ganglia calcification0CASR CL E G H8461514OMIM:601198Hypocalcemia, autosomal dominant 1272
HP:0002135HP:0002135Basal ganglia calcification0COX1 CL E G H45127419ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0COX2 CL E G H45137421ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0COX3 CL E G H45147422ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0CYP2U1 CL E G H11361220582OMIM:615030Spastic paraplegia 56, autosomal recessiveHP:0040283 - Occasional18
HP:0002135HP:0002135Basal ganglia calcification0DNM1L CL E G H100592973ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040284 - Very rare94
HP:0002135HP:0002135Basal ganglia calcification0ERCC3 CL E G H20713435OMIM:610651Xeroderma pigmentosum, complementation group B.54
HP:0002135HP:0002135Basal ganglia calcification0ERCC4 CL E G H20723436ORPHA:90321Cockayne syndrome type 1HP:0040281 - Very frequent158
HP:0002135HP:0002135Basal ganglia calcification0ERCC6 CL E G H20743438OMIM:214150Cerebrooculofacioskeletal syndrome 1199
HP:0002135HP:0002135Basal ganglia calcification0ERCC6 CL E G H20743438ORPHA:90321Cockayne syndrome type 1HP:0040281 - Very frequent199
HP:0002135HP:0002135Basal ganglia calcification0ERCC6 CL E G H20743438ORPHA:90324Cockayne syndrome type 3HP:0040281 - Very frequent199
HP:0002135HP:0002135Basal ganglia calcification0ERCC6 CL E G H20743438OMIM:133540Cockayne syndrome, type B.199
HP:0002135HP:0002135Basal ganglia calcification0ERCC6 CL E G H20743438OMIM:278800De Sanctis-Cacchione syndrome199
HP:0002135HP:0002135Basal ganglia calcification0ERCC8 CL E G H11613439OMIM:216400Cockayne syndrome A.55
HP:0002135HP:0002135Basal ganglia calcification0ERCC8 CL E G H11613439ORPHA:90321Cockayne syndrome type 1HP:0040281 - Very frequent55
HP:0002135HP:0002135Basal ganglia calcification0ERCC8 CL E G H11613439ORPHA:90324Cockayne syndrome type 3HP:0040281 - Very frequent55
HP:0002135HP:0002135Basal ganglia calcification0FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndromeHP:0040282 - Frequent8
HP:0002135HP:0002135Basal ganglia calcification0FAM111A CL E G H6390124725OMIM:127000Kenny-caffey syndrome, type 2.8
HP:0002135HP:0002135Basal ganglia calcification0GATA3 CL E G H26254172OMIM:146255Hypoparathyroidism, sensorineural deafness, and renal dysplasia83
HP:0002135HP:0002135Basal ganglia calcification0GJA1 CL E G H26974274OMIM:164200Oculodentodigital dysplasia.68
HP:0002135HP:0002135Basal ganglia calcification0GNA11 CL E G H27674379OMIM:615361Hypocalcemia, autosomal dominant 2HP:0040283 - Occasional16
HP:0002135HP:0002135Basal ganglia calcification0GNAS CL E G H27784392ORPHA:79443Pseudohypoparathyroidism type 1AHP:0040282 - Frequent101
HP:0002135HP:0002135Basal ganglia calcification0GNAS CL E G H27784392ORPHA:79444Pseudohypoparathyroidism type 1CHP:0040282 - Frequent101
HP:0002135HP:0002135Basal ganglia calcification0GNAS CL E G H27784392OMIM:103580Pseudohypoparathyroidism, type IA.101
HP:0002135HP:0002135Basal ganglia calcification0GNAS CL E G H27784392OMIM:612462Pseudohypoparathyroidism, type IC.101
HP:0002135HP:0002135Basal ganglia calcification0IFIH1 CL E G H6413518873OMIM:615846Aicardi-Goutieres syndrome 7.28
HP:0002135HP:0002135Basal ganglia calcification0ISG15 CL E G H96364053OMIM:616126Immunodeficiency 38 with basal ganglia calcification4
HP:0002135HP:0002135Basal ganglia calcification0JAM2 CL E G H5849414686OMIM:618824BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 8, AUTOSOMAL RECESSIVE; IBGC8
HP:0002135HP:0002135Basal ganglia calcification0LSM11 CL E G H13435330860OMIM:619486AICARDI-GOUTIERES SYNDROME 8; AGS8
HP:0002135HP:0002135Basal ganglia calcification0MYORG CL E G H5746219918OMIM:618317Basal ganglia calcification, idiopathic, 7, autosomal recessive
HP:0002135HP:0002135Basal ganglia calcification0ND1 CL E G H45357455ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0ND4 CL E G H45387459ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0ND5 CL E G H45407461ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0ND6 CL E G H45417462ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0OPA1 CL E G H49768140ORPHA:98673Autosomal dominant optic atrophy, classic formHP:0040284 - Very rare214
HP:0002135HP:0002135Basal ganglia calcification0PDGFB CL E G H51558800OMIM:213600Basal ganglia calcification, idiopathic, 1.9
HP:0002135HP:0002135Basal ganglia calcification0PDGFB CL E G H51558800OMIM:615483Basal ganglia calcification, idiopathic, 5.9
HP:0002135HP:0002135Basal ganglia calcification0PDGFRB CL E G H51598804OMIM:213600Basal ganglia calcification, idiopathic, 1.28
HP:0002135HP:0002135Basal ganglia calcification0PDGFRB CL E G H51598804OMIM:615007Basal ganglia calcification, idiopathic, 4.28
HP:0002135HP:0002135Basal ganglia calcification0PSMB8 CL E G H56969545OMIM:256040Proteasome-associated autoinflammatory syndrome 1 and digenic forms20
HP:0002135HP:0002135Basal ganglia calcification0PSMG2 CL E G H5698424929OMIM:619183PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4
HP:0002135HP:0002135Basal ganglia calcification0RNASEH2B CL E G H7962125671OMIM:610181Aicardi-Goutieres syndrome 234
HP:0002135HP:0002135Basal ganglia calcification0RNU7-1 CL E G H10014774434033OMIM:619487AICARDI-GOUTIERES SYNDROME 9; AGS9
HP:0002135HP:0002135Basal ganglia calcification0SAMHD1 CL E G H2593915925OMIM:612952Aicardi-Goutieres syndrome 5.55
HP:0002135HP:0002135Basal ganglia calcification0SLC20A2 CL E G H657510947OMIM:213600Basal ganglia calcification, idiopathic, 1.70
HP:0002135HP:0002135Basal ganglia calcification0SLC25A46 CL E G H9113725198OMIM:616505Neuropathy, hereditary motor and sensory, type VIB14
HP:0002135HP:0002135Basal ganglia calcification0SLC46A1 CL E G H11323530521OMIM:229050Folate malabsorption, hereditary.101
HP:0002135HP:0002135Basal ganglia calcification0SNORD118 CL E G H72767632952ORPHA:542310Leukoencephalopathy with calcifications and cysts6
HP:0002135HP:0002135Basal ganglia calcification0TREM2 CL E G H5420917761OMIM:618193POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL231
HP:0002135HP:0002135Basal ganglia calcification0TREX1 CL E G H1127712269OMIM:225750Aicardi-Goutieres syndrome 156
HP:0002135HP:0002135Basal ganglia calcification0TRNF CL E G H45587481ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TRNH CL E G H45647487ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TRNL1 CL E G H45677490ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TRNQ CL E G H45727495ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TRNS1 CL E G H45747497ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TRNS2 CL E G H45757498ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TRNW CL E G H45787501ORPHA:550MELASHP:0040282 - Frequent
HP:0002135HP:0002135Basal ganglia calcification0TYROBP CL E G H730512449OMIM:221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.22
HP:0002135HP:0002135Basal ganglia calcification0XPR1 CL E G H921312827OMIM:616413Basal ganglia calcification, idiopathic, 64


Genes (49) :ACVR1 CA2 CASR COX1 COX2 COX3 CYP2U1 DNM1L ERCC3 ERCC4 ERCC6 ERCC8 FAM111A GATA3 GJA1 GNA11 GNAS IFIH1 ISG15 JAM2 LSM11 MYORG ND1 ND4 ND5 ND6 OPA1 PDGFB PDGFRB PSMB8 PSMG2 RNASEH2B RNU7-1 SAMHD1 SLC20A2 SLC25A46 SLC46A1 SNORD118 TREM2 TREX1 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW TYROBP XPR1

Diseases (43) :OMIM:135100 ORPHA:2785 OMIM:259730 OMIM:601198 ORPHA:550 OMIM:615030 ORPHA:98673 OMIM:610651 ORPHA:90321 OMIM:214150 ORPHA:90324 OMIM:133540 OMIM:278800 OMIM:216400 ORPHA:93325 OMIM:127000 OMIM:146255 OMIM:164200 OMIM:615361 ORPHA:79443 ORPHA:79444 OMIM:103580 OMIM:612462 OMIM:615846 OMIM:616126 OMIM:618824 OMIM:619486 OMIM:618317 OMIM:213600 OMIM:615483 OMIM:615007 OMIM:256040 OMIM:619183 OMIM:610181 OMIM:619487 OMIM:612952 OMIM:616505 OMIM:229050 ORPHA:542310 OMIM:618193 OMIM:225750 OMIM:221770 OMIM:616413
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.